Answers are grounded in this paper and cite their sources.
This analysis demonstrates T2 mapping in COPD patients, indicating potential for a lung biomarker and better monitoring.
Motivation: Chronic Obstructive Pulmonary Disease (COPD) causes progressive lung damage, and periodic monitoring of these structural changes is crucial for understanding disease progression. Goal(s): To develop a safe non-contrast MRI technique for accurate T2* mapping in COPD patients. Approach: Three healthy subjects and two COPD patients were scanned on a 3T MRI with the ΔTE UTE sequence, using closely spaced ΔTE echoes and analyzed with mono- and bi-exponential T2* mapping. Results: ΔTE UTE successfully mapped the differences in T2* between healthy and emphysema lung tissue, correlating with emphysema regions identified on CT, suggesting its potential as a biomarker tool in COPD. Impact: The ΔTE UTE technique enables safe, non-ionizing imaging suitable for repeated exams in longitudinal monitoring of COPD progression. By enhancing T2* mapping sensitivity, it shows promise as a potential biomarker for detecting subtle lung changes, complementing current CT assessments.
No takes yet. Share an insight, caveat, or question.
Malis et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: